Updated:
Finorpa
Finorpa SCR is anchored in its territory and invests in equity and quasi-equity in SMEs and companies with potential. Captech Santé is a venture capital fund...
Finorpa
Finorpa SCR is anchored in its territory and invests in equity and quasi-equity in SMEs and companies with potential. Captech Santé is a venture capital fund specialized in health technologies, intervening from early development phases (seed to series A) in biotech, medtech, e-health and nutrition. Hauts-de-France Avenir TPE PME is a regional co-investment fund dedicated to financing the development and takeover of TPE/PME.
General information
Firm type
Private Equity
Year founded
1984
Location
Region
Europe
Country
France
City
Lille
Corporate office
4 square Dutilleul, 59800 Lille, France
Additional offices
Maison du Développement, 16 place Victor Hugo, 62500 Saint-Omer, France · 6 boulevard de Belfort, 80000 Amiens, France
Principals
Jean-Yves Bacon
Sector focus
Frequently asked questions
How is Finorpa structured and what vehicles does it manage?
Finorpa operates through three distinct funds. Finorpa SCR invests equity and quasi-equity in regional SMEs and holds a mixed public-private shareholder base. Captech Santé is a venture capital fund focused on deeptech startups in health, investing from seed to Series A across biotech, medtech, e-health and nutrition. Hauts-de-France Avenir TPE PME is a regional co-investment fund that partners with private investors on development and buyout-stage TPE/PME deals, providing up to €500,000 per transaction.
What is Finorpa's geographic investment focus?
The firm is deeply anchored in the Hauts-de-France region of northern France. Its offices in Lille, Saint-Omer and Amiens reflect a deliberately local deployment strategy, and the investment mandate of each fund is tied to the regional economy. Finorpa does not market a national or cross-border investment scope.
Does Finorpa participate in fund commitments or only direct deals?
Finorpa invests directly in companies across its three vehicle strategies. Hauts-de-France Avenir TPE PME operates as a co-investment fund alongside private capital partners such as other investment funds, family offices and business angels. There is no indication of a fund-of-funds program in the disclosed strategy.
What investment stages and ticket sizes does Finorpa target?
Through Captech Santé, the firm targets early-stage health-tech companies from seed to Series A. Hauts-de-France Avenir TPE PME targets development and buyout-stage TPE/PME with ticket sizes up to €500,000. Finorpa SCR pursues a long-term, flexible capital approach for regional SMEs across growth phases.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: